On November 15, 2019, and February 21, 2020, the Pharmacy and Therapeutics (P&T) Committee approved Clinical Criteria applicable to the medical drug benefit for Empire BlueCross BlueShield (Empire). These policies were developed, revised or reviewed to support clinical coding edits.


The Clinical Criteria is publicly available on the Empire provider website, and the effective dates will be reflected in the Clinical Criteria Web Posting February 2020. Visit Clinical Criteria to search for specific policies.


For questions or additional information, use this email.


EBSCRNU-0109-20 April 2020


Featured In:
July 2020 Empire Provider News